(392 days)
Not Found
Not Found
No
The summary describes a powered toothbrush utilizing radiofrequency energy and tactile vibration, controlled by a simple push button and light indicators. There is no mention of any adaptive learning, pattern recognition, or data analysis that would indicate the presence of AI/ML. The clinical studies focus on the device's physical effects and user interaction, not on any intelligent processing of data.
Yes
The device is intended for the "prevention and treatment of gingivitis," which is a medical condition, making it a therapeutic device.
No
The device is described as a toothbrush intended for oral hygiene, including reduction of plaque and prevention/treatment of gingivitis. Its function is to clean and treat, not to diagnose a condition.
No
The device description explicitly states it is a "handheld rechargeable electric toothbrush" comprised of a handle, brush head, and recharging unit, indicating it is a physical hardware device.
Based on the provided information, the ToothWave™ device is not an In Vitro Diagnostic (IVD).
Here's why:
- Definition of IVD: An In Vitro Diagnostic device is a medical device intended for use in vitro for the examination of specimens, including blood and tissue samples, derived from the human body, solely or principally for the purpose of providing information concerning a physiological or pathological state, or concerning a congenital abnormality, or to determine the safety and compatibility with potential recipients, or to monitor therapeutic measures.
- ToothWave™'s Intended Use: The ToothWave™ is a toothbrush intended to promote good oral hygiene, including reduction of plaque and the prevention and treatment of gingivitis. It is used directly on the teeth and gums within the oral cavity.
- Lack of Specimen Examination: The device does not examine any specimens derived from the human body in vitro. It applies radiofrequency energy and tactile vibration directly to the oral tissues.
Therefore, the ToothWave™ falls under the category of a medical device, but specifically a powered toothbrush for oral hygiene, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
ToothWave™ is a powered radiofrequency toothbrush intended to promote good oral hygiene, including reduction of plaque and the prevention and treatment of gingivitis. ToothWave™ is intended for over-the-counter use.
Product codes (comma separated list FDA assigned to the subject device)
QMJ
Device Description
The ToothWave™ is a handheld rechargeable electric toothbrush intended to promote oral hygiene, including reduction in plaque and prevention and treatment of gingivitis. The device is for over-the-counter (OTC) use. The device is comprised of the handle, the brush head, and recharging unit. The device utilizes radiofrequency (RF) energy and tactile vibration. The device is operated by a single-mode push button located on the handle/user interface board and includes a set of light indicators informing the user of the device operation (RF activation, vibration level, charging, or error).
The device is charged using a rechargeable base unit that is inductively charged and galvanically isolated from the handle of the unit. The ToothWave™ toothbrush is equipped with four operation modes: no vibration (0 Hz), low vibration (275Hz), medium vibration (300Hz), and high vibration (400Hz). The RF generator generates low power conductive RF frequencies of 3.0 MHz±0.3MHz once turned on for operation; the maximum power output is 3W in all operating modes.
The handle is equipped with an ON/OFF switch and indicator panel that indicates the device status (RF activation, vibration level, charging, or error). The device is turned on by a long press of the ON/OFF switch and the mode is selected by cvcling through the options using a short press of the ON/OFF switch.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Teeth, Oral Cavity, Gums
Indicated Patient Age Range
The device is contraindicated for persons below the age of 18. The study population included generally healthy adult subjects between the ages of 18 – 70. Self-selection study included subjects with age range from 22 to 84 years old.
Intended User / Care Setting
Home-use, over-the-counter (OTC) use by lay users.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
A single-blinded, double arm, randomized prospective study was conducted.
Population: Generally healthy adult subjects between the ages of 18 – 70 who had a moderate level of gingivitis, calculus, and a level of plaque consistent with "plaque formers."
Sample Size: 86 subjects composed of 45 in the treatment group and 41 in the control group.
Data Source: Clinical study with visits every 4 weeks. Safety assessment via dental examination, and compliance with study protocol.
Annotation Protocol: At baseline and 6 weeks, subjects were assessed for:
- Amount of plaque using the Navy Plague Index (RMNPI).
- Amount of calculus on the lingual surface of the anterior mandibular teeth using the Volpe-Manhold Index (V-MI).
- Gingivitis using the Modified Gingival Index (MGI) and Gingival Bleeding Index (GBI) measures.
Subjects were randomized to ToothWave™ with radiofrequency and low vibration speed or a power toothbrush without radiofrequency (control).
For usability and self-selection studies:
Sample Size: 55 participants (45 for usability, 10 for self-selection).
Data Source: User performance evaluation received toothbrushes in original package with complete user manual.
Annotation Protocol:
- Usability: 45 subjects identified themselves as eligible users and performed a single treatment session according to instructions while observed. Completed post-treatment questionnaire and labeling comprehension exam.
- Self-selection: 10 subjects (5 potential end users, 5 contraindicated) independently decided eligibility based on device labeling. Completed post-reading questionnaire and labeling comprehension exam.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
TOOTHWAVE DEVICE EFFICACY AND SAFETY CLINICAL STUDY
- Study Type: Single-blinded, double arm, randomized prospective study, including clinic visits conducted every 4 weeks.
- Sample Size: 86 subjects (45 in the treatment group, 41 in the control group).
- Key Results:
- Following 6 weeks of brushing, the treatment group showed statistically significant reductions in all tested measures (plaque, calculus, gingivitis) compared to the control group.
- The delta values of all measured scores were statistically significantly greater in the treatment group compared to the control.
- No device related adverse events were reported.
- Calculated difference (delta) from baseline following 6 weeks of twice daily brushings:
- MGI: Treat -44.99%, Control -31.35%
- GBI: Treat -34.57%, Control -2.78%
- RMNPI: Treat -25.19%, Control -14.93%
- Post hoc analysis showed 2% accumulation of tartar in the treatment group and 14% accumulation of tartar in the control group.
TOOTHWAVE USABILITY & SELF-SELECTION CLINICAL STUDY
- Study Type: Usability and self-selection study.
- Sample Size: 55 participants (45 for usability evaluation, 10 for self-selection study).
- Key Results:
- Usability evaluation: All 45 eligible subjects identified themselves as potential users, completed device-related tasks safely and properly within 10 minutes with no assistance or adverse events. Post-treatment questionnaires and labeling comprehension test indicated users found instructions easy to understand.
- Self-selection study: All 5 eligible potential lay end users correctly identified themselves as eligible, and all 5 contraindicated subjects correctly self-excluded themselves from use, based on the device labeling materials.
- All 55 participants demonstrated labeling comprehension.
THE TOOTHWAVE SAFETY (HIGH VIBRATION SPEED) CLINICAL STUDY REPORT
- Study Type: Single-blind, randomized double arm prospective study.
- Sample Size: 86 subjects (43 using ToothWave™ with high vibration frequency and RF activation, 43 using a control power toothbrush).
- Key Results: Oral soft tissue examination conducted every 2 weeks showed no adverse events reported.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
- MGI (Gingivitis): Treatment group reduction from baseline: -44.99%. Control group reduction from baseline: -31.35%.
- GBI (Gingival Bleeding Index): Treatment group reduction from baseline: -34.57%. Control group reduction from baseline: -2.78%.
- RMNPI (Navy Plaque Index): Treatment group reduction from baseline: -25.19%. Control group reduction from baseline: -14.93%.
- Tartar Accumulation (post hoc): Treatment group: 2% accumulation. Control group: 14% accumulation.
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 872.6866 Radiofrequency toothbrush.
(a)
Identification. A radiofrequency toothbrush is a device that consists of a handle containing a radiofrequency generator to deliver radiofrequency energy to a brush intended to be applied to the teeth. The device is intended to remove adherent plaque and food debris from the teeth to reduce tooth decay.(b)
Classification. Class II (special controls). The special controls for this device are:(1) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested, and detailed protocols must be provided for each test conducted:
(i) Validation of the radiofrequency performance specifications including output power, voltage output, radiofrequency, pulse cycle, waveform, and pulse duration;
(ii) Temperature performance testing to evaluate the temperature change of the device, structures of the oral cavity (including skin, tissue, and dental restorations), and toothpaste under worst-case conditions;
(iii) An assessment of mechanical output specifications and physical properties including vibration frequency, tuft retention, brush head strength, and battery voltage; and
(iv) Use life and durability testing.
(2) A label comprehension and self-selection study must demonstrate that the intended user population can understand the package labeling and correctly choose the device for the indicated use.
(3) Usability performance evaluation must demonstrate that the user can safely and correctly use the device, based solely on reading the directions for use.
(4) The patient-contacting components of the device must be demonstrated to be biocompatible.
(5) Electrical safety, thermal safety, mechanical safety, battery safety, and electromagnetic compatibility (EMC) testing must be performed.
(6) Software verification, validation, and hazard analysis must be performed.
(7) Labeling must include:
(i) Information on how the device operates, including images or illustrations;
(ii) A detailed summary of the device technical specifications;
(iii) A warning which states that the use of this device is not a substitute for regular visits to a dentist for routine clinical care;
(iv) Instructions on how to clean and maintain the device; and
(v) The use life and disposal of the components of the device.
0
DE NOVO CLASSIFICATION REQUEST FOR TOOTHWAVE™
REGULATORY INFORMATION
FDA identifies this generic type of device as:
Radiofrequency toothbrush. A radiofrequency toothbrush is a device that consists of a handle containing a radiofrequency generator to deliver radiofrequency energy to a brush intended to be applied to the teeth. The device is intended to remove adherent plaque and food debris from the teeth to reduce tooth decay.
NEW REGULATION NUMBER: 21 CFR 872.6866
CLASSIFICATION: Class II
PRODUCT CODE: QMJ
BACKGROUND
DEVICE NAME: ToothWave™
SUBMISSION NUMBER: DEN190039
DATE DE NOVO RECEIVED: August 22, 2019
SPONSOR INFORMATION:
Home Skinovations Ltd. Tabor Building, Shaar Yokneam Yoqneam Illit, 2069200 ISRAEL
INDICATIONS FOR USE
ToothWave™ is indicated as follows:
ToothWave™ is a powered radiofrequency toothbrush intended to promote good oral hygiene, including reduction of plaque and the prevention and treatment of gingivitis. ToothWave™ is intended for over-the-counter use.
LIMITATIONS
Limitations on device use are achieved through the following statements included in the Instructions for Use Manual:
1
Contraindications:
"This device including all its parts must not be used by the following people: persons below the age of 18, those with limited physical, sensory or psychological capacities, those lacking experience or knowledge in how to use the device in a safe way, or those who do not understand the hazards involved."
"Do not use the device if you:
- Have a pacemaker, internal defibrillator, another active implanted device, or if . you have any medical concerns about using this device.
- Have a history of oral cancer or oropharyngeal cancer, or have any other type of ● cancer, or have pre-malignant lesions.
- Have an impaired immune system due to immunosuppressive diseases such as ● HIV, or you use immunosuppressive medication.
- Are pregnant or nursing."
Warnings:
"The device is for home-use. The handle may be used by multiple persons, but for reasons of hygiene, each user must use their own brush head."
"Use of this device is not a substitute for regular visits to the dentist for routine clinical care."
"Consult your physician before use if you:
- Have concurrent conditions, such as heart disorders, seizures, uncontrolled high blood pressure, liver or kidney diseases.
- . Have poorly controlled hormone disorders, such as diabetes or thyroid abnormalities."
"Consult your dentist before use if you:
- Have had oral or gum surgery in the last two months. ●
- Have severely injured gums." .
PLEASE REFER TO THE LABELING FOR A COMPLETE LIST OF WARNINGS, PRECAUTIONS AND CONTRAINDICATIONS.
DEVICE DESCRIPTION
Overview
The ToothWave™ is a handheld rechargeable electric toothbrush intended to promote oral hygiene, including reduction in plaque and prevention and treatment of gingivitis. The device is for over-the-counter (OTC) use. The device is comprised of the handle, the brush head, and recharging unit. The device utilizes radiofrequency (RF) energy and tactile vibration. The device is operated by a single-mode push button located on the handle/user interface board and includes
2
a set of light indicators informing the user of the device operation (RF activation, vibration level, charging, or error):
Image /page/2/Figure/1 description: The image shows a diagram of a toothbrush with labeled parts. The brush head is labeled as number 1, and the handheld unit is labeled as number 2. The barrier and electrodes are labeled as number 3, the on/off switch is labeled as number 4, and the indicator lights are labeled as number 5.
Figure 1: ToothWave Device over ooth Wave Device m
The device is charged using a rechargeable base unit that is inductively charged and galvanically isolated from the handle of the unit. The ToothWave™ toothbrush is equipped with four operation modes: no vibration (0 Hz), low vibration (275Hz), medium vibration (300Hz), and high vibration (400Hz). The RF generator generates low power conductive RF frequencies of 3.0 MHz±0.3MHz once turned on for operation; the maximum power output is 3W in all operating modes.
The handle is equipped with an ON/OFF switch and indicator panel that indicates the device status (RF activation, vibration level, charging, or error). The device is turned on by a long press of the ON/OFF switch and the mode is selected by cvcling through the options using a short press of the ON/OFF switch.
Brush Head
The device includes one small brush head with a contains tufts of bristles. Within the brush head, there are two RF electrodes. The silicon barrier is intended to protect the electrodes. The brush head is used to brush all surfaces of the teeth for 2 minutes with a slight vibration every 30 seconds. The user is intended to gently press the bristles against the teeth, and move the brush in circular movements, slowly and systematically from tooth. After 2 minutes, the device will shut down automatically. Each user must use their own brush head and is to be replaced every three months. In addition, the brush head is to be replaced if the bristles, silicone strip, or electrodes become loose, bent, damaged, or crushed.
3
Image /page/3/Picture/0 description: The image shows a close-up of an electric toothbrush head. The toothbrush head has a silicone barrier and RF electrodes. The RF electrodes are located at the base of the toothbrush head, and the silicone barrier is located at the top of the toothbrush head.
Image /page/3/Picture/1 description: The image shows a close-up of a toothbrush head. The toothbrush has a white handle and a head with blue bristles. There is a green piece in the center of the toothbrush head. The toothbrush is angled slightly to the left.
Figure 4: Graphic Representation of the ToothWave™ Brush Head
Handheld Unit
The handheld unit has a plastic outside and contains the RF generator, vibration motor, RF electrode connector, microcontroller unit, and the control panel. The functions of each of the components of the handheld unit is as follows:
- RF generator generates 3 MHz RF with maximal output power of 3W. .
- . Vibration motor – used for vibrating the brush head with a vibration frequency of: 0Hz, 275Hz, 300Hz and 400Hz.
- RF electrode connector used for RF signal transference. .
- Microcontroller unit The microcontroller unit is responsible for the following tasks: ●
- Monitoring the ON/OFF switch and controlling the LED indicators. O
- Controlling the RF. O
- Controlling the vibration of the brush head. O
- Control panel The control panel includes the ON/OFF switch and 6 indicator LEDs. . There are six LED indicators located on the front of the handheld brush, four white indicators indicating the selected operation mode, the fifth orange LED indicates the battery status mode, and the sixth green LED indicates the charging mode.
Image /page/3/Figure/13 description: The image shows a drawing of an electric toothbrush and four different modes. The toothbrush has a head with bristles and a handle with a button. The four modes are labeled Mode1, Mode2, Mode3, and Mode4. Each mode has a different pattern of lines and symbols.
Figure 1 - Handheld Unit and Control Panel
4
Adapter and Charger Base
There is one US adapter for the device. This adapter connects the charging base to the wall outlet. The charger base unit runs on 5V DC. An AC/DC power adapter with USB output of 5V DC is connected to the charger base, which transmits 60 kHz electromagnetic energy to charge the internal battery in the handheld unit. Following are the power adapter input specifications:
- Input voltage: 100-240V ●
- Input Frequency: 50/60Hz
- Input Current: 0.2A ●
Image /page/4/Picture/5 description: The image shows a charging station for an electric toothbrush. On the left, there is a charging base with a USB cable coiled next to it. On the right, the toothbrush is placed on a charging base, and a cable connects the base to a wall outlet.
Figure 2 - Charger Base Unit and Adapter
Device Specifications
| Model no. | H7001 |
|---|---|
| Technology | DentalRF™ and vibration |
| Vibration | 0; 275Hz; 300Hz or 400Hz (± 5%) |
| Radio frequency | 3MHz ±0.3MHz; up to 3W |
| Package size | (W)165 (H)227 (D)80 [mm] |
| System weight | 115g |
| Transport & storage | |
| between uses and storage | |
| condition | Temperature: - 40 to 70°C |
| Relative humidity : 10 to 90%rH | |
| Atmospheric pressure: 500 to 1060hPa | |
| Operating conditions | Temperature: 5 to 40°C |
| Relative humidity: 15 to 90%rH | |
| Atmospheric pressure: 700 to 1060hPa | |
| Time from minimum | |
| storage temperature | |
| between uses to | |
| minimum operating | |
| temperature with ambient | |
| temperature of 20°C | 30 minutes |
| Time from maximum | |
| storage temperature | |
| between uses to | |
| maximum operating | |
| temperature with ambient | |
| temperature of 20°C | 30 minutes |
| Protection against | |
| electric shock | Class I medical equipment |
| type BF applied part | |
| Adapter | YH-S06U0500600 (USA) |
| Input: | |
| Output: | 100 - 240V; 50/60Hz; 0.2A |
| 5.0Vdc; 0.6A | |
| Mode of operation | Non-continuous |
| Waterfproof rating: | |
| USB adapter (IPX4) | Protection assured against water |
| splashing | |
| Charging cradle (IPX7) | |
| Handle (IP67) | Protection assured against water |
| immersion at a depth of up to 1 meter, | |
| for a maximum of 30 minutes. | |
| The device was tested and | |
| complies with | IEC 60601-1 (Safety) |
| IEC 60601-2-2 (RF Safety) | |
| IEC 60601-1-2 (EMC) | |
| IEC 60601-1-11 (Environment) | |
| Service life of the | 5 years |
5
SUMMARY OF NONCLINICAL/BENCH STUDIES
Non-clinical/bench studies conducted on the ToothWave™ device contribute to a demonstration of the device performance characteristics:
BIOCOMPATIBILITY/MATERIALS
The patient contacting component of the ToothWave™. The device was evaluated with respect to its intended use per ISO 10993-1:2003, Biological evaluation of medical devices and FDA Guidance "Use of International Standard ISO 10993-1, 'Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process". Testing was performed on final finished device. The device is a surface device in contact with intact skin and mucosal membrane for a limited duration. The following tests were performed on the toothbrush body/brush head, silicon barrier, RF brush head electrodes, and toothbrush bristles.
- Cytotoxicity per ISO 10993-5 .
- . Sensitization per ISO 10993-10
- Irritation per ISO 10993-10
The results supported the biocompatibility of the ToothWave™.
SHELF LIFE/STERILITY
The device is not provided sterile nor end user sterilized. The handle may be used by multiple persons, but for reasons of hygiene, each user must use their own brush head. After use, the brush head and handle are to be washed under running water to remove any toothpaste or debris. If there remains any stuck on debris, the brush head is to be replaced.
The ToothWave™ brush head and handle/handpiece underwent a life time test to assess device durability. The lifetime test results demonstrated the durability, stability and reliable performance of both the brush head and handpiece/handle for the designated lifetime of the ToothWave toothbrush (3 months for the brush head and 5 years for the handle/hand piece).
ELECTROMAGNETIC CAPABILITY & ELECTROMAGNETIC SAFETY
Electromagnetic Compatibility (EMC):
The ToothWave™ was evaluated for conformance to IEC 60601-1-2 Edition 4.0 (2014) and was found to comply with all applicable requirements of this EMC testing standard.
Electrical Safety:
The ToothWave™ was evaluated for conformance to AAMI/ANSI 60601-1, (2012) medical electrical equipment - part 1: general requirements for basic safety and essential
6
performance (IEC 60601-1:2005. Mod). Review of the results concluded that the device complies with all the electrical safety requirements specified in this standard.
The following additional electrical safety and EMC testing was performed:
- . IEC 60601-1-11:2010, Medical electrical equipment Part 1-11 - Requirements for the medical electrical equipment and medical electrical systems used in the home healthcare environment.
- IEC 60601-2-2: 2017, Medical electric equipment, part 2: particular requirements for the basic safety and essential performance of high frequency surgical equipment and high frequency accessories.
- IEC 60601-1-6:2010, medical electrical equipment part 1-6, general requirements ● for safety - collateral standard: usability.
- IEC 62304:2015, Medical device software, software life-cycle processes.
- ISO 20127:2005. Dentistry -- Powered toothbrushes -- General requirements and ● test methods.
- IEC 60335-2-52:2002, Safety of Household and Similar Electrical Appliances Part 2: Particular Requirements for Oral Hygiene Appliances. IEC 62133:2012, Secondary Cells and Batteries Containing Alkaline or Other Non- Acid Electrolytes - Safety Requirements for Portable Sealed Secondary
- IEC 60335-2-52:2002. Safety of Household and Similar Electrical Appliances ● Part 2: Particular Requirements for Oral Hygiene Appliances.
- EN55014-1:2006 Electromagnetic compatibility - Requirements for household appliances, electric tools and similar apparatus - Part 1: Emission
- EN55014-2:2006 Electromagnetic compatibility Requirements for household ● appliances, electric tools and similar apparatus - Part 2: Immunity
- . EN61000-3-2:2014 Electromagnetic compatibility (EMC) - Part 3-2: Limits -Limits for harmonic current emissions (equipment input current up to and including 16A per phase)
- EN61000-3-3:2013 Electromagnetic compatibility (EMC) Part 3-3: Limits -● Limitation of voltage changes, voltage fluctuations and flicker in public low voltage supply systems, for equipment with rated current ITT Analysis Set ) | 86 | 91.5 |
| Number of Subjects Withdrew Consent after Randomization | (b) (4) | |
Table - Patient Accountability
11
| Characteristic | ToothWaveTM | Control | Overall | |
|---|---|---|---|---|
| N=45 | N=41 | |||
| Age | Mean age (SD) | 44.9 (14.42) | 46 (11.52) | 45.4(13.05) |
| Age range | 18-70 | 23-66 | 18-70 | |
| Gender | Male (%) | 15 (33.3%) | 13 (31.7%) | 28 (32.6%) |
| Female (%) | 30 (66.7%) | 28 (68.3%) | 58 (67.4%) | |
| Race | Caucasian (%) | 36 (80%) | 35 (85.4%) | 71 (82.6%) |
| Black, Non-Hispanic (%) | 6 (13.3%) | 4 (9.8%) | 10 (11.6%) | |
| Asian Pacific Islander | ||||
| (%) | 2 (4.4%) | 1 (2.4%) | 2 (2.3%) | |
| American Indian / | ||||
| Alaskan Native (%) | 1 (2.2%) | 1 (2.4%) | 2 (2.3%) |
Table - Baseline Demographic Characteristics (ITT)
Results
A total of 86 subjects (45 in the treatment group and 41 in the control) completed the study and comprise the cohort for safety and efficacy analyses. At baseline, the test groups did not differ significantly in the efficacy measurement mean scores. Following 6 weeks of brushing the test group showed statistically significant reductions in all the tested measures compared to the control group. In addition, the delta values of all measured scores were statistically significantly greater in the treatment group compared to the control. No device related adverse events were reported during the study.
Table - Calculated difference (delta) from baseline following 6 weeks of twice daily brushings
| | | N (randomized) | N (completed) | Baseline
Mean (SD) | 6 weeks
Mean (SD) | Delta
Mean (SD) | mean percent
change |
|-------|---------|----------------|---------------|-----------------------|----------------------|--------------------|------------------------|
| MGI | Treat | 45 | 44 | (b) (4) | | | -44.99 |
| | Control | 41 | 41 | | | | -31.35 |
| GBI | Treat | 45 | 44 | | | | -34.57 |
| | Control | 41 | 41 | | | | -2.78 |
| RMNPI | Treat | 45 | 44 | | | | -25.19 |
| | Control | 41 | 41 | | | | -14.93 |
12
*In a post hoc analysis, the results showed a 2% accumulation of tartar in the treatment group and 14% accumulation of tartar in the control group.
TOOTHWAVE USABILITY & SELF-SELECTION CLINICAL STUDY
Objective
To test that the ToothWave™ (Model H7001) device may be used properly and safely by potential lay end users, under actual use conditions. Additionally, this evaluation is intended to confirm that contraindicated lay users successfully self-exclude themselves from use of the device and that the labeling content is accurately understood by potential lay end users.
Investigation Design
Two studies were conducted and summarized in study report DO116538A. The usability study component was conducted as part of the "Safety and Efficacy of the ToothWave™ Toothbrush (Model H7001) Home Use Device for Reduction of Dental Plaque and Calculus and Treatment and Prevention of Gingivitis ToothWave™ Clinical Study" (Study protocol #DO116217A) with the 45 study subjects assigned to the treatment group. The second study (Study Protocol #DO116508A) was conducted in 10 subjects and was aimed to assure self-exclusion of potential lay users who are not eligible for device use. All of the participants that were included in this user performance evaluation (n=55) received the toothbrushes in their original package with the complete user manual, as intended for marketing. The 45 subjects in the usability evaluation were asked to correctly identify themselves as potential eligible lay end users of the ToothWave™ toothbrush and perform a single treatment session according to the device instructions while being observed only (without intervention.) The self-selection evaluation included 10 subjects (5 potential end users and 5 contraindicated subjects), who independently decided whether they were eligible or contraindicated for device use, based on the device labeling (user manual and box label), but did not perform any treatment. The usability subjects (n=45) completed a post-treatment questionnaire and the self-selection subjects (n=10) completed post-reading questionnaire. All subjects completed a labeling comprehension exam.
| Table 2: Subjects' age | ||||
|---|---|---|---|---|
| Usability | ||||
| evaluation | Self-selection | |||
| study | Total | |||
| Age | N | 45 | 10 | 55 |
| Mean | 44.9 | 49.1 | 45.7 | |
| SD | 14.4 | 22.3 | 16.0 | |
| Min | 18 | 22 | 18 | |
| Max | 70 | 84 | 84 | |
| Med | 46 | 41 | 45 |
13
| Table 3: Distribution of gender | ||||||
|---|---|---|---|---|---|---|
| Gender | Usability evaluation | Self-selection study | Total | |||
| N | % | N | % | N | % | |
| Female | 30 | 66.7% | 8 | 80% | 38 | 69% |
| Male | 15 | 33.3% | 2 | 20% | 17 | 31% |
Success Criteria
Study success was determined as study subjects assigned to the use of ToothWave™ would properly and safely use the device under actual use conditions/ability to correctly understand the user manual and device labeling materials.
All 55 participants in the usability and self-selection study would demonstrate labeling comprehension in the labeling comprehension exam.
For the self-selection study, 5 intended users would identify themselves as potential users of the device, while the 5 contraindicated subjects would able to self-exclude from use of the device.
Results
Usability evaluation:
Subjects' age ranged from 18 to 70 years old, with an average age of 44.9 (±14.4) years. 30 (66.7%) subjects were females and 15 (33.3%) subjects were males. All of the eligible 45 subjects identified themselves as potential users of the device and completed the device related tasks in less than 10 minutes with no requests for assistance. No adverse events were reported during the treatment. Results of post treatment questionnaires and labeling comprehension test indicated a good experience of the potential lay users, who found it easy to understand the instructions for use and perform the device related tasks.
Self-selection study:
Subjects' age ranged from 22 to 84 years old, with an average age of 49.1 (±22.3) years. Eight (80%) subjects were females and 2 (20%) subjects were males. All 5 eligible potential lay end users identified themselves as eligible to use the device and all 5 contraindicated subjects selfexcluded themselves from use, based on the device labeling materials (user manual and box label).
THE TOOTHWAVE SAFETY (HIGH VIBRATION SPEED) CLINICAL STUDY REPORT
An additional clinical safety analysis was conducted based on a second comparative clinical study conducted with the ToothWave™ device used with the high vibration frequency (400Hz) in conjunction with the RF activation to evaluate (n = 86) in a single-blind, randomized double arm prospective study with subjects randomized to a group using ToothWave™ (n=43) or a control power toothbrush, for 6 weeks with an oral soft tissue examination conducted every 2 weeks with no adverse events reported.
14
Pediatric Extrapolation
In this De Novo request, existing clinical data were not leveraged to support the use of the device in a pediatric patient population.
LABELING
The sponsor provided labeling includes a user manual and packaging label for the ToothWave™ The user manual includes the Indications for Use and a description of how the device works, how to use the device, maintenance of the device, and warnings/precautions/contraindications for use of the device. The user manual also summarizes the clinical data. The device is intended for over-the-counter use, therefore, the language used in the user manual uses common, layperson language. To clarify the use of the device with respect to the supporting data provided to demonstrate safety and effectiveness, the device labeling was revised to including the following:
- . Contraindication that this device including all its parts must not be used by the following people: children, adults below the age of 18, those with limited physical, sensory or psychological capacities, those lacking experience or knowledge in how to use the device in a safe way, or those who do not understand the hazards involved.
- . The device is for home-use. The handle may be used by multiple person, but for reasons of hygiene, each user must use their own brush head.
- . The Use of the device is not a substitute for regular visits to the dentist for routine clinical care.
- . To consult your physician/dentist before use if you have conditions such as heart disorder, seizures, uncontrolled high blood pressure, liver or kidney disease, diabetes, oral or gum surgery in the last two months, or severely injured gums.
The user manual describes the packaging contents of the controls, and settings. The device is used for two (2) minutes, morning and evening to brush the teeth and gums. The brush head is to be replaced every three (3) months. The user manual states to check the brush head prior to each use for signs of damage such as excessive wear and/or biofilm accumulation. The brush head is to be replaced if there are signs of damage. The user manual contains instructions of the cleaning and maintenance of the device. Directions for disposal of the components are the device are provided within the user manual. In addition, the user manual identifies the technical specifications of the device including the radio frequency (3MHz ±0.3MHz; up to 3W) and vibration (0; 275Hz; 300Hz or 400Hz (± 5%)). The company name and contact information is provided in the user manual.
15
RISKS TO HEALTH
The table below identifies the risks to health that may be associated with use of the radiofrequency toothbrush and the measures necessary to mitigate these risks.
| Identified Risks to Health | Mitigation Measures |
|---|---|
| Thermal injury (mucosal or | |
| unintentional skin overheating/burn) | Non-clinical performance testing |
| Software validation, verification, and hazard analysis | |
| Electrical safety testing | |
| Electromagnetic compatibility (EMC) testing | |
| Labeling | |
| Adverse tissue reaction | Biocompatibility evaluation |
| Mechanical injury to the oral cavity | Electrical safety testing |
| Non-clinical performance testing | |
| Labeling | |
| Electromagnetic interference or | |
| electrical shock | Electrical safety testing |
| Electromagnetic compatibility (EMC) testing | |
| Battery safety testing | |
| Labeling | |
| Incorrect use or operation of the | |
| device causing harm or injury to the | |
| user | Non-clinical performance testing |
| Usability evaluation | |
| Use life testing | |
| Electrical safety testing | |
| Labeling | |
| Gingival irritation or recession, | |
| tooth sensitivity or pain by failure to | |
| identify correct population and | |
| condition | Label comprehension and self-selection study |
| Labeling |
Table - Identified Risks to Health and Mitigation Measures
SPECIAL CONTROLS
In combination with the general controls of the FD&C Act. the radiofrequency toothbrush is subject to the following special controls:
- (1) Non-clinical performance testing must demonstrate that the device performs as intended under anticipated conditions of use. The following performance characteristics must be tested, and detailed protocols must be provided for each test conducted:
- Validation of the RF performance specifications including output power, voltage 1. output, radiofrequency, pulse cycle, waveform, and pulse duration;
- ii. Temperature performance testing to evaluate the temperature change of the device, structures of the oral cavity (including skin, tissue, and dental restorations), and toothpaste under worst-case conditions;
- iii. An assessment of mechanical output specifications and physical properties including vibration frequency, tuft retention, brush head strength, and battery voltage; and
16
- iv. Use life and durability testing.
- (2) A label comprehension and self-selection study must demonstrate that the intended user population can understand the package labeling and correctly choose the device for the indicated use.
- (3) Usability performance evaluation must demonstrate that the user can safely and correctly use the device, based solely on reading the directions for use.
- (4) The patient-contacting components of the device must be demonstrated to be biocompatible.
- (5) Electrical safety, thermal safety, mechanical safety, battery safety, and electromagnetic compatibility (EMC) testing must be performed.
- (6) Software verification, validation, and hazard analysis must be performed.
- (7) Labeling must include:
- Information on how the device operates, including images or illustrations; 1.
- ii. A detailed summary of the device technical specifications;
- A warning which states that the use of this device is not a substitute for regular iii. visits to a dentist for routine clinical care;
- Instructions on how to clean and maintain the device: and iv.
- The use life and disposal of the components of the device. v.
BENEFIT-RISK DETERMINATION
The benefits of the device align with the benefits of other powered vibrating bristle head toothbrushes, to reduce/remove plaque on tooth surfaces and treatment and prevention of gingivitis, an inflammatory condition of gingiva secondary to plaque accumulation; the daily use of the ToothWave™ device as directed can provide the benefit of reduced plaque and reduced plaque accumulation, and treatment and prevention of gingivitis. The probable benefits of the ToothWave™ device are based on the clinical performance testing provided, and the improvements seen in plaque reduction and gingival bleeding is substantial. The label comprehension and self-selection study was conducted to assess the effectiveness of the package labeling for the intended OTC users to understand and correctly choose this device for themselves to reduce plaque and for treatment and prevention of gingivitis. The ToothWave™ device labeling appears to mitigate potential user error associated with device use and to allow the user to identify the correct population and condition for the device. The label comprehension and self-selection study demonstrated that the intended OTC users can understand the package labeling and correctly choose this device for themselves for reduction of plaque and treatment and prevention of gingivitis.
The expected adverse events include gingival irritation, damage to gingival texture and contour. and tooth sensitivity. Based on the clinical performance testing provided, including the report of no adverse events, the probability of each of these adverse events is very low. Patients reported
17
acceptable rates of satisfaction. Additional factors to be considered in determining probable risks and benefits for the ToothWave™ device include: the limitations of the device per the instructions in the labeling. One such limitation is that the device should not be used if the consumer experiences continued gingival irritation after two weeks of regular use. The safety and effectiveness of the ToothWave™ device has not been established for subjects with implanted electrical devices such as pacemakers. Both limitations are described in the package labeling.
In conclusion, given the available information summarized above, the data supports that for general population consumers, the probable benefits outweigh the probable risks for the ToothWave™ device to reduce plaque and for treatment and prevention of gingivitis.
Patient Perspectives
This submission did not include specific information on patient perspectives for this device.
Benefit/Risk Conclusion
In conclusion, given the available information above, for the following indication statement:
ToothWave™ is a powered radiofrequency toothbrush intended to promote good oral hygiene, including reduction of plaque and the prevention and treatment of gingivitis. ToothWave™ is intended for over-the-counter use.
The probable benefits outweigh the probable risks for the ToothWave™. The device provides benefits and the risks can be mitigated by the use of general controls and the identified special controls.
CONCLUSION
The De Novo for the ToothWave™ is granted and the device is classified as follows:
Product Code: OMJ Device Type: Radiofrequency toothbrush Regulation Number: 21 CFR 872.6866 Class: II